I agree that management have been very good at managing expectations. This was a solid result explained in part by higher margin in arhi business as a result of lower than expected claims growth, with claims inflation currently at historical lows.
I would be interested in your thoughts on what you consider to be a good buying opportunity in the coming months. Looking expensive at current levels given consensus price target $6.00 (10 analysts). Trading on a PE around 25 which does not appear commensurate with forecast EPS Growth.
Ann: Appendix 4E & 2018 Annual Report, page-3
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NHF (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$7.35 |
Change
0.010(0.14%) |
Mkt cap ! $3.565B | |||
| Open | High | Low | Value | Volume |
| $7.23 | $7.35 | $7.17 | $5.434M | 745.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 520 | $7.33 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $7.35 | 5324 | 3 |
View Market Depth
| Last trade - 16.10pm 27/06/2024 (20 minute delay) ? |
| NHF (ASX) Chart |